Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REVAKI-2 trial of sildenafil for prevention of acute kidney injury after cardiac surgery
2015-003259-24Phase 2Completed
- Sponsor
- University of Leicester
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in acute kidney failure (AKF) comparing Sildenafil arm with Placebo arm (2 arms). Primary endpoint: Serum creatinine over 7 days after surgery. Started Oct 2015; status: completed.
02
Drugs
sildenafil
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on 2015-003259-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003259-24.